August 12, 2025 • 14 mins
The healthcare technology landscape is undergoing a profound transformation with a White House-led initiative dubbed "Make Health Technology Great Again" that aims to create a streamlined approach to health data sharing through a nationwide tracking system.
• Accelerated interoperability in health data can transform brand strategies by enabling precision targeting and improved patient engagement
• Innovation teams can fast-track development of scalable digital health solutions with fewer technical or regulatory hurdles
• Patient access and support teams can shift from reactive to proactive approaches with real-time insurance verification and smart routing
• Patients benefit through less paperwork, more personalized support, faster access to treatments, and better engagement leading to improved outcomes
• Digital companions like Medisafe can deliver contextualized interventions that work around the clock to support patients' therapeutic journeys
• The initiative addresses significant gaps in current healthcare delivery, including the 38% of prescriptions that go unfilled in the first 30 days
Thanks for joining us on Postscripts. If you found this conversation valuable, follow or subscribe for more insights at the intersection of pharma technology and patient impact at postscriptspodcast.com.
PostScripts Rx is not intended to constitute medical advice, nor is it intended to influence prescribing decisions or any other medical or clinical decision-making. All medical and clinical judgment and decision-making, prescribing decisions, and all related considerations remain exclusively the responsibility of providers and patients.
Mark as Played
Transcript
Episode Transcript
Available transcripts are automatically generated. Complete accuracy is not guaranteed.
Speaker 1 (00:00):
Welcome to Postscripts, the podcast
exploring what happens afterthat first prescription.
We cover the latest innovationsin patient access, support,
digital tools, HCP engagementand pharma marketing that drive
better outcomes.
This podcast is forinformational purposes only and
does not constitute medicaladvice or influence clinical
decision-making.
Patients should always consulttheir healthcare professionals.
(00:21):
Welcome to the podcast.
My name is Brian Carr and I'mthe Senior Vice President of
Marketing at Medisafe, althoughany of the opinions expressed
here are my own and notnecessarily those of Medisafe or
its partners.
So here's what's happening.
We're seeing making healthtechnology great again, what
this would mean for pharmainnovation and patients.
We're seeing a new especiallyin the US here a new era of
digital health policy startingto unfold.
(00:42):
We've some calling it the makehealth technology great again
mission, and at its core themovement is you know, it's a
regulatory, operational push tostreamline, modernize,
democratize, some people sayaccess to health data,
spareheaded by this renewedWhite House efforts, and really
would culminate in policies thatease the sharing of health
(01:04):
records.
This transformation could bringprofound implications not only
for the pharma and life scienceindustries, but for health care
innovators and, most importantly, patients.
So today we figured we'd unpackthree key impacts that we see
that may happen from this ofthis sort of health tech refresh
on the life science and pharmacompanies, and specifically what
it means for pharma's datastrategies and digital
(01:24):
therapeutics, how innovationteams can leverage that
interoperability initiatives andwhy patient access and support
teams might have to reimaginesome of their connectivity.
Finally, we'll take a quicklook at how patients benefit
from this shift in policy,although some of that is
self-evident.
So let's look at the firstimpact that we really think
we'll see.
It's going to be acceleratedaccess to this term.
(01:45):
You're going to hear more ofinteroperability in health data
and how that can transform abrand strategy.
Right, this new White House planto ease the sharing of
computerized health records.
It really does aim to create aseamless, what we call
interoperability through anationwide data tracking system.
Right, this could reduce thetime it takes, for example, for
life science companies to accessreal-world data.
(02:07):
It would really fuelpersonalized care in those
day-to-day digital engagementsthat we see here at Medisafe and
other companies do as well, aswell as some targeted therapies
and the impacts of themedications being used for them.
So, according to the Departmentof Health and Human Services,
the goal of this new movement isreally to unify data across
providers and public healthdepartments and we've seen these
(02:29):
initiatives in the past.
But this really is a time whereit does have major benefits for
the brand marketers.
Right, because you'll haveprecision targeting.
For example, with unified EHRdata, pharma marketers can
deliver tailored messaging tospecific ACPs or patient cohorts
at just the right moment whenthey know that moment in the
care journey.
Right, so you can also imagine,for pharma marketers in
(02:51):
particular, an improved patientengagement funnel.
Right, knowing where thatpatient is in their treatment,
in their journey, in theirtimeline, really can improve
timing for the digitalcompanions and digital solutions
onboarding, co-pay support,refill reminders, things like
that.
Right, and then stronger healthoutcomes can be imagined.
You see, digital companionecosystems we know personally of
(03:14):
some that you know increaseadherence rates well into the
double digits, you know, andthey personalize that digital
support per the condition or thetherapy, or the medication and
or the patient itself.
Those can become exponentiallymore powerful when they are fed.
You know, interoperable patientdata for continuous ongoing
optimization, honestly, on adaily and even hourly basis.
(03:35):
You know we did see a Decemberreport by the ONC it was about
December, I think, 2023, thatonly four in 10 hospitals were
sharing patient data in realtime with external organizations
, right.
So on the one hand, that's good.
It's for privacy reasons.
We understand that.
And before you share any dataout, you want to make sure
whoever is catching or receivingthat data is just as compliant
(03:58):
or even more compliant than youare, right?
So that takes a lot oftrustworthiness and auditing and
back and forth.
So to fix that bottleneck youcould have richer, faster data
pipelines for all the compliantstakeholders.
But especially this could behelpful for pharma brand teams
who really are aiming for thatomni-channel relevance.
So innovation teams they couldfast track development of some
(04:21):
scalable digital healthsolutions.
Fast-track development of somescalable digital health
solutions.
This could be a really bigshift brought on to the movement
because innovation teams canhave fewer technical or
regulatory hurdles when they'rebuilding these digital tools
around health records data right.
There was a recent article onUSA Today actually in other
media outlets, this is July 31st2025, really did highlight some
of the plan to make it easierfor these third-party apps and
(04:43):
platforms like MetaSafe toreally integrate directly with
EHR systems.
It does align with the policyof the 21st Century Cures Act,
which was enacted a few yearsago but now really kind of has
some teeth in enforcement.
So, you may recall, a few yearsago there was, you know,
obviously, the smart on fireprotocols where Apps and life
science companies could write toa specific similar coding
(05:06):
language and get datainteroperability back and forth
between platforms thattheoretically may compete in the
marketplace, but if a patientwanted their data transferred or
they got a new doctor, theywent to a new hospital health
system.
You want to seamlessly makesure those records follow the
patient, so there were someprotocols put in place for that.
However, now there is thedifference here is there's teeth
and enforcement with what theWhite House has really proposed
(05:27):
back in July here and that could, you know, really accelerate
development of some digitalhealth solutions without a need
for those custom integration foreach individual health systems,
ehr and really, you know, thosedesign and plug and play.
We could just have more plugand play platforms sitting atop
a national health ITinfrastructure with a single
(05:48):
coding language and singleaccess points, et cetera, that
everyone agrees to in the dataand is handled with compliant
partners in a secure manner.
So Medisave, for example, wecould use our AI engine.
We've got what we calljust-in-time interventions.
We can inform really hyperpersonalized digital nudges
based on real-time health datathat we're seeing from other
(06:08):
sources you know that arecompliant within the ecosystem.
You know we can identifyintervention triggers based on
adherence patterns andtheoretically, if approved by
the people using the platform,they could contribute those
adherence patterns as well withopt-in and privacy protocols
obviously, and it's all be, youknow, personal information right
of go across that they weren'tagreeing to right, so it would
(06:28):
be anonymized data.
Here's a trend we're seeing ifsomeone's on a certain
medication they haven't taken,for example, the last two doses,
we see some trends that maybeyou know.
Here's some interventions thatwe've seen work on our platform
to really make sure they're onfor that second or third dose,
et cetera, et cetera.
So you can see where thosesharings could go into an
ecosystem and really haveimpactful results for patients.
(06:49):
You know, even Accenture it wasabout a year ago they came up
with a survey where, you know,94% of pharma executives said
you know, build a connectedpatient ecosystem.
It's a top three priority forthe next three years and the
challenge there is achievingscale.
So if you want to integrateright now with an EHR system,
you need to have an EHR partnerthat is also integrated into
that system so they catch yourdata and the challenge there is
(07:12):
you can integrate to an EHR, butthen one of the challenges is
you have to find a partnerthat's also integrated in the
EHR.
Then you and the partner haveto agree yes, we will.
We are compliant and we'vepassed all the protocols that we
are satisfied that we willtransfer data to each other, as
opposed to data to the nationalexchange, where we all are
compliant.
Going that way, we don't haveto have a separate agreement.
For example, you know you wouldhave to have a separate
(07:33):
agreement, but the protocolsdon't have to be individual
one-offs with everyone you wantto partner with.
So this interoperability canbring scale.
That's what I'm trying to sayhere and it's not just a
buzzword.
And with federal backing, ifthere's teeth to it and they're
saying there is real teeth andmomentum to get a national
health database that a lot ofcompliant partners can tie into
(07:53):
and really drive impacts forpatients, it can be a practical
reality.
That really does let thosepharma innovation teams leapfrog
any technical barriers andreally start focusing on the
value creation through, you know, clinical grade, even digital
companions and digital solutions.
Third big impact we're seeinglikely is, you know, access
teams could really reimaginetheir onboarding adherence or
(08:14):
cost transparency.
You know, when health techreally does communicate better
with each other, especially withreal-time platforms.
Patient access support you cansee shifting from being reactive
to proactive right, this canopen the door for next-gen
services that are dynamic,contextual and timely.
You know, for pharma access andaffordability teams what that
(08:36):
really means is.
You'd see real-time insuranceverification, for example,
patient eligibility checks,smart routing for benefit
investigation and supportservices.
You know, like with platforms,you know Medisafe we have our
care connector.
You can see really smartrouting, especially if there's a
national database where we'reall compliant and contributing
into it.
You could see improved refillonboarding flows because you're
(08:56):
going to see triggered EHR data,right, so you're being
discharged from the hospital.
We know that prescription'sgoing through.
You've given permissions tosome digital platforms.
Hey, let me know.
When it's arrived at mypharmacy, you go in and pick it
up and then we can actuallytrack okay, they've picked up
the medication and they have arefill in 30 days, et cetera, et
cetera.
So when you can integrate thoseHCP and patient workflows, it
(09:18):
really will make case managementmore intelligent, more
efficient, and when you put anational data grid in play on
that, pharma can really reducedelays in getting therapies to
patients, and think of the boostfor first fill conversion rates
, right?
So studies show approximately38% of prescriptions go unfilled
.
If you're listening to thispodcast, you've probably heard
that stat before.
They go unfilled in the first30 days due to some access
(09:41):
barriers.
That's IQVIA data coming out acouple of years ago, and
real-time systems can reallypinpoint and preempt those gaps
by identifying whether it'sinsurance frictions really
trigger communications early.
Hey, we noticed you haven'tpicked up your medication.
Do you want it sent to you?
Do you need an Uber or a rideto the pharmacy?
Things like that can reallyhelp with some of the ways we
(10:02):
can get those first scriptsfilled.
So patients how are they goingto benefit?
Well, speed, simplicity andsupport across the whole
treatment journey, right?
So if you have this nationaltech database for health data,
that transformation it's notjust about abstract systems,
which to some extent it is.
It's really about people.
The biggest windfall you'regoing to see for patients is
(10:23):
less paperwork, delivering morecare, right, because the data is
flowing freely.
Patients no longer need totransfer their records from
provider to provider.
We see this at Medisafe.
We have digital dock exchangewhere, if someone needs to
submit their proof of income.
For you know, say, a digitalcopay card that we have within
the platform.
You don't need even a hardcopay card anymore to show the
pharmacist, you could just showtheir phone.
(10:44):
Here it is, here's the balancethat's left on the copay card
anymore.
To show the pharmacist, youcould just show their phone,
here it is, here's the balancethat's left on the copay card.
But to do that you need tosubmit, say, for example, proof
of income, right?
So to do that you have to do itsecurely.
And years ago you have to gofind a fax machine, fax it off,
because that was a secure,encrypted protocol.
Well, now, with MetaSafe andother digital solutions, you
take a picture of your licenseor your auth form form or
whatever it is, a W-2, it's sentencrypted into the encrypted
(11:05):
platform that receives it andyour support team could say, yep
, they've already qualified.
It used to take a week ofwaiting for the fax to arrive on
someone's desk.
Your support team is now atmost five to seven minutes
taking a picture, getting itthrough, and then they get their
notification in the platform.
So they're off to the races.
Much less paperwork, deliveringmore care, more personalized
support, right?
(11:25):
So you see digital companionslike Medisafe and others, we
really can deliver thoseinterventions contextualized to
a patient's clinical and dailyreality.
So, for example, we know, bythe way, for Brian it's Tuesday
afternoon.
It's very difficult for him totake a medication.
For some reason he's alwaysmissing his Tuesday afternoon
medications.
You can get an individualized,personalized extra notifications
(11:47):
or interventions on a Tuesdayafternoon to make sure Brian
stays on his path right.
So also, I think you're goingto see patients getting faster
access to treatments.
You've got real-timepre-authorization access
workflows can seriously reducedelay-related deterioration on
the way for documentation to getin or approvals.
You'll probably see betterengagement and better outcomes.
Patients who understand andstick with their therapies
(12:08):
typically have better odds anddigital engagement boosts, you
know adherence can be seen up toyou know, 20, 25% in some cases
, depending on the digitalsolutions.
So you know this is a jointimpact we kind of call connected
confidence, giving patientsthat self-awareness and efficacy
that they are confident indealing with their therapeutic
journey.
So the patient knows they'resupported, not just by their
(12:29):
care team, but you know thisdigital infrastructure works
around the clock on their behalfand gives them control of their
own data.
You know if they left town,they went on vacation or
something like that their data.
They don't have to spend a lotgetting there if it's a lot in a
national database.
Wherever the hospital, healthsystem or clinic they go to can
pull up their documentation andsee it and get them back on
their way whether they losttheir medication.
(12:49):
One of the use cases we've seenis people who are caught in
natural disaster areas andflooding, for example.
They leave the house in a rush,they are now up in a shelter
and they don't have theirmedication anymore, even if they
were smart enough to rememberto take it out of the house with
them.
They ran out right.
So if there's a nationaldatabase, we know where it is.
It just would streamline things.
They can get their medicationnow, but this could actually
(13:10):
make it easier for them.
So where are we going next withthis?
Well, the revitalization ofnational health tech
infrastructure.
It's not just a political move.
It really is that operationalimperative and it can be a real
breakthrough.
I think you're going to seecampaigns become smarter, better
timed.
These new technologies aregoing to reach patients faster.
Patient experience will reflecttrue coordination, not being so
(13:31):
fragmented, and you're going tosee predictive AI come into
play digital companions,compassionate care, connectors
and coaches.
It's all going to grow as aresult and the opportunity is
not just to use the tools butreally connect them and build
that you know cohesive patientexperience that can give both
medical and emotional support topatients.
So, again, in closing, you knowthat push to make health tech
(13:52):
great again can be bringing realpolicy and infrastructure
change.
Now to healthcare data systems.
I still believe patients willgain access to faster, better
support and face fewer barriersto adherence with solutions that
are digital and data-enhancedand engaged, like Medisafe and
others, well-positioned toreally help patients get the
most out of their impacts.
(14:12):
All right, and I want to thankyou so much for joining us on
Postscripts.
If you want to join, or, by allmeans, contact us at
postscriptspodcastcom If youfound this conversation valuable
, follow or subscribe for moreinsights at the intersection of
pharma technology and patientimpact.
Until next time, keep lookingforward.
Thanks.
Welcome to Postscripts, the podcast
exploring what happens afterthat first prescription.
We cover the latest innovationsin patient access, support,
digital tools, HCP engagementand pharma marketing that drive
better outcomes.
This podcast is forinformational purposes only and
does not constitute medicaladvice or influence clinical
decision-making.
Patients should always consulttheir healthcare professionals.
(00:21):
Welcome to the podcast.
My name is Brian Carr and I'mthe Senior Vice President of
Marketing at Medisafe, althoughany of the opinions expressed
here are my own and notnecessarily those of Medisafe or
its partners.
So here's what's happening.
We're seeing making healthtechnology great again, what
this would mean for pharmainnovation and patients.
We're seeing a new especiallyin the US here a new era of
digital health policy startingto unfold.
(00:42):
We've some calling it the makehealth technology great again
mission, and at its core themovement is you know, it's a
regulatory, operational push tostreamline, modernize,
democratize, some people sayaccess to health data,
spareheaded by this renewedWhite House efforts, and really
would culminate in policies thatease the sharing of health
(01:04):
records.
This transformation could bringprofound implications not only
for the pharma and life scienceindustries, but for health care
innovators and, most importantly, patients.
So today we figured we'd unpackthree key impacts that we see
that may happen from this ofthis sort of health tech refresh
on the life science and pharmacompanies, and specifically what
it means for pharma's datastrategies and digital
(01:24):
therapeutics, how innovationteams can leverage that
interoperability initiatives andwhy patient access and support
teams might have to reimaginesome of their connectivity.
Finally, we'll take a quicklook at how patients benefit
from this shift in policy,although some of that is
self-evident.
So let's look at the firstimpact that we really think
we'll see.
It's going to be acceleratedaccess to this term.
(01:45):
You're going to hear more ofinteroperability in health data
and how that can transform abrand strategy.
Right, this new White House planto ease the sharing of
computerized health records.
It really does aim to create aseamless, what we call
interoperability through anationwide data tracking system.
Right, this could reduce thetime it takes, for example, for
life science companies to accessreal-world data.
(02:07):
It would really fuelpersonalized care in those
day-to-day digital engagementsthat we see here at Medisafe and
other companies do as well, aswell as some targeted therapies
and the impacts of themedications being used for them.
So, according to the Departmentof Health and Human Services,
the goal of this new movement isreally to unify data across
providers and public healthdepartments and we've seen these
(02:29):
initiatives in the past.
But this really is a time whereit does have major benefits for
the brand marketers.
Right, because you'll haveprecision targeting.
For example, with unified EHRdata, pharma marketers can
deliver tailored messaging tospecific ACPs or patient cohorts
at just the right moment whenthey know that moment in the
care journey.
Right, so you can also imagine,for pharma marketers in
(02:51):
particular, an improved patientengagement funnel.
Right, knowing where thatpatient is in their treatment,
in their journey, in theirtimeline, really can improve
timing for the digitalcompanions and digital solutions
onboarding, co-pay support,refill reminders, things like
that.
Right, and then stronger healthoutcomes can be imagined.
You see, digital companionecosystems we know personally of
(03:14):
some that you know increaseadherence rates well into the
double digits, you know, andthey personalize that digital
support per the condition or thetherapy, or the medication and
or the patient itself.
Those can become exponentiallymore powerful when they are fed.
You know, interoperable patientdata for continuous ongoing
optimization, honestly, on adaily and even hourly basis.
(03:35):
You know we did see a Decemberreport by the ONC it was about
December, I think, 2023, thatonly four in 10 hospitals were
sharing patient data in realtime with external organizations
, right.
So on the one hand, that's good.
It's for privacy reasons.
We understand that.
And before you share any dataout, you want to make sure
whoever is catching or receivingthat data is just as compliant
(03:58):
or even more compliant than youare, right?
So that takes a lot oftrustworthiness and auditing and
back and forth.
So to fix that bottleneck youcould have richer, faster data
pipelines for all the compliantstakeholders.
But especially this could behelpful for pharma brand teams
who really are aiming for thatomni-channel relevance.
So innovation teams they couldfast track development of some
(04:21):
scalable digital healthsolutions.
Fast-track development of somescalable digital health
solutions.
This could be a really bigshift brought on to the movement
because innovation teams canhave fewer technical or
regulatory hurdles when they'rebuilding these digital tools
around health records data right.
There was a recent article onUSA Today actually in other
media outlets, this is July 31st2025, really did highlight some
of the plan to make it easierfor these third-party apps and
(04:43):
platforms like MetaSafe toreally integrate directly with
EHR systems.
It does align with the policyof the 21st Century Cures Act,
which was enacted a few yearsago but now really kind of has
some teeth in enforcement.
So, you may recall, a few yearsago there was, you know,
obviously, the smart on fireprotocols where Apps and life
science companies could write toa specific similar coding
(05:06):
language and get datainteroperability back and forth
between platforms thattheoretically may compete in the
marketplace, but if a patientwanted their data transferred or
they got a new doctor, theywent to a new hospital health
system.
You want to seamlessly makesure those records follow the
patient, so there were someprotocols put in place for that.
However, now there is thedifference here is there's teeth
and enforcement with what theWhite House has really proposed
(05:27):
back in July here and that could, you know, really accelerate
development of some digitalhealth solutions without a need
for those custom integration foreach individual health systems,
ehr and really, you know, thosedesign and plug and play.
We could just have more plugand play platforms sitting atop
a national health ITinfrastructure with a single
(05:48):
coding language and singleaccess points, et cetera, that
everyone agrees to in the dataand is handled with compliant
partners in a secure manner.
So Medisave, for example, wecould use our AI engine.
We've got what we calljust-in-time interventions.
We can inform really hyperpersonalized digital nudges
based on real-time health datathat we're seeing from other
(06:08):
sources you know that arecompliant within the ecosystem.
You know we can identifyintervention triggers based on
adherence patterns andtheoretically, if approved by
the people using the platform,they could contribute those
adherence patterns as well withopt-in and privacy protocols
obviously, and it's all be, youknow, personal information right
of go across that they weren'tagreeing to right, so it would
(06:28):
be anonymized data.
Here's a trend we're seeing ifsomeone's on a certain
medication they haven't taken,for example, the last two doses,
we see some trends that maybeyou know.
Here's some interventions thatwe've seen work on our platform
to really make sure they're onfor that second or third dose,
et cetera, et cetera.
So you can see where thosesharings could go into an
ecosystem and really haveimpactful results for patients.
(06:49):
You know, even Accenture it wasabout a year ago they came up
with a survey where, you know,94% of pharma executives said
you know, build a connectedpatient ecosystem.
It's a top three priority forthe next three years and the
challenge there is achievingscale.
So if you want to integrateright now with an EHR system,
you need to have an EHR partnerthat is also integrated into
that system so they catch yourdata and the challenge there is
(07:12):
you can integrate to an EHR, butthen one of the challenges is
you have to find a partnerthat's also integrated in the
EHR.
Then you and the partner haveto agree yes, we will.
We are compliant and we'vepassed all the protocols that we
are satisfied that we willtransfer data to each other, as
opposed to data to the nationalexchange, where we all are
compliant.
Going that way, we don't haveto have a separate agreement.
For example, you know you wouldhave to have a separate
(07:33):
agreement, but the protocolsdon't have to be individual
one-offs with everyone you wantto partner with.
So this interoperability canbring scale.
That's what I'm trying to sayhere and it's not just a
buzzword.
And with federal backing, ifthere's teeth to it and they're
saying there is real teeth andmomentum to get a national
health database that a lot ofcompliant partners can tie into
(07:53):
and really drive impacts forpatients, it can be a practical
reality.
That really does let thosepharma innovation teams leapfrog
any technical barriers andreally start focusing on the
value creation through, you know, clinical grade, even digital
companions and digital solutions.
Third big impact we're seeinglikely is, you know, access
teams could really reimaginetheir onboarding adherence or
(08:14):
cost transparency.
You know, when health techreally does communicate better
with each other, especially withreal-time platforms.
Patient access support you cansee shifting from being reactive
to proactive right, this canopen the door for next-gen
services that are dynamic,contextual and timely.
You know, for pharma access andaffordability teams what that
(08:36):
really means is.
You'd see real-time insuranceverification, for example,
patient eligibility checks,smart routing for benefit
investigation and supportservices.
You know, like with platforms,you know Medisafe we have our
care connector.
You can see really smartrouting, especially if there's a
national database where we'reall compliant and contributing
into it.
You could see improved refillonboarding flows because you're
(08:56):
going to see triggered EHR data,right, so you're being
discharged from the hospital.
We know that prescription'sgoing through.
You've given permissions tosome digital platforms.
Hey, let me know.
When it's arrived at mypharmacy, you go in and pick it
up and then we can actuallytrack okay, they've picked up
the medication and they have arefill in 30 days, et cetera, et
cetera.
So when you can integrate thoseHCP and patient workflows, it
(09:18):
really will make case managementmore intelligent, more
efficient, and when you put anational data grid in play on
that, pharma can really reducedelays in getting therapies to
patients, and think of the boostfor first fill conversion rates
, right?
So studies show approximately38% of prescriptions go unfilled
.
If you're listening to thispodcast, you've probably heard
that stat before.
They go unfilled in the first30 days due to some access
(09:41):
barriers.
That's IQVIA data coming out acouple of years ago, and
real-time systems can reallypinpoint and preempt those gaps
by identifying whether it'sinsurance frictions really
trigger communications early.
Hey, we noticed you haven'tpicked up your medication.
Do you want it sent to you?
Do you need an Uber or a rideto the pharmacy?
Things like that can reallyhelp with some of the ways we
(10:02):
can get those first scriptsfilled.
So patients how are they goingto benefit?
Well, speed, simplicity andsupport across the whole
treatment journey, right?
So if you have this nationaltech database for health data,
that transformation it's notjust about abstract systems,
which to some extent it is.
It's really about people.
The biggest windfall you'regoing to see for patients is
(10:23):
less paperwork, delivering morecare, right, because the data is
flowing freely.
Patients no longer need totransfer their records from
provider to provider.
We see this at Medisafe.
We have digital dock exchangewhere, if someone needs to
submit their proof of income.
For you know, say, a digitalcopay card that we have within
the platform.
You don't need even a hardcopay card anymore to show the
pharmacist, you could just showtheir phone.
(10:44):
Here it is, here's the balancethat's left on the copay card
anymore.
To show the pharmacist, youcould just show their phone,
here it is, here's the balancethat's left on the copay card.
But to do that you need tosubmit, say, for example, proof
of income, right?
So to do that you have to do itsecurely.
And years ago you have to gofind a fax machine, fax it off,
because that was a secure,encrypted protocol.
Well, now, with MetaSafe andother digital solutions, you
take a picture of your licenseor your auth form form or
whatever it is, a W-2, it's sentencrypted into the encrypted
(11:05):
platform that receives it andyour support team could say, yep
, they've already qualified.
It used to take a week ofwaiting for the fax to arrive on
someone's desk.
Your support team is now atmost five to seven minutes
taking a picture, getting itthrough, and then they get their
notification in the platform.
So they're off to the races.
Much less paperwork, deliveringmore care, more personalized
support, right?
(11:25):
So you see digital companionslike Medisafe and others, we
really can deliver thoseinterventions contextualized to
a patient's clinical and dailyreality.
So, for example, we know, bythe way, for Brian it's Tuesday
afternoon.
It's very difficult for him totake a medication.
For some reason he's alwaysmissing his Tuesday afternoon
medications.
You can get an individualized,personalized extra notifications
(11:47):
or interventions on a Tuesdayafternoon to make sure Brian
stays on his path right.
So also, I think you're goingto see patients getting faster
access to treatments.
You've got real-timepre-authorization access
workflows can seriously reducedelay-related deterioration on
the way for documentation to getin or approvals.
You'll probably see betterengagement and better outcomes.
Patients who understand andstick with their therapies
(12:08):
typically have better odds anddigital engagement boosts, you
know adherence can be seen up toyou know, 20, 25% in some cases
, depending on the digitalsolutions.
So you know this is a jointimpact we kind of call connected
confidence, giving patientsthat self-awareness and efficacy
that they are confident indealing with their therapeutic
journey.
So the patient knows they'resupported, not just by their
(12:29):
care team, but you know thisdigital infrastructure works
around the clock on their behalfand gives them control of their
own data.
You know if they left town,they went on vacation or
something like that their data.
They don't have to spend a lotgetting there if it's a lot in a
national database.
Wherever the hospital, healthsystem or clinic they go to can
pull up their documentation andsee it and get them back on
their way whether they losttheir medication.
(12:49):
One of the use cases we've seenis people who are caught in
natural disaster areas andflooding, for example.
They leave the house in a rush,they are now up in a shelter
and they don't have theirmedication anymore, even if they
were smart enough to rememberto take it out of the house with
them.
They ran out right.
So if there's a nationaldatabase, we know where it is.
It just would streamline things.
They can get their medicationnow, but this could actually
(13:10):
make it easier for them.
So where are we going next withthis?
Well, the revitalization ofnational health tech
infrastructure.
It's not just a political move.
It really is that operationalimperative and it can be a real
breakthrough.
I think you're going to seecampaigns become smarter, better
timed.
These new technologies aregoing to reach patients faster.
Patient experience will reflecttrue coordination, not being so
(13:31):
fragmented, and you're going tosee predictive AI come into
play digital companions,compassionate care, connectors
and coaches.
It's all going to grow as aresult and the opportunity is
not just to use the tools butreally connect them and build
that you know cohesive patientexperience that can give both
medical and emotional support topatients.
So, again, in closing, you knowthat push to make health tech
(13:52):
great again can be bringing realpolicy and infrastructure
change.
Now to healthcare data systems.
I still believe patients willgain access to faster, better
support and face fewer barriersto adherence with solutions that
are digital and data-enhancedand engaged, like Medisafe and
others, well-positioned toreally help patients get the
most out of their impacts.
(14:12):
All right, and I want to thankyou so much for joining us on
Postscripts.
If you want to join, or, by allmeans, contact us at
postscriptspodcastcom If youfound this conversation valuable
, follow or subscribe for moreinsights at the intersection of
pharma technology and patientimpact.
Until next time, keep lookingforward.
Thanks.
Popular Podcasts
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.
My Favorite Murder with Karen Kilgariff and Georgia Hardstark
My Favorite Murder is a true crime comedy podcast hosted by Karen Kilgariff and Georgia Hardstark. Each week, Karen and Georgia share compelling true crimes and hometown stories from friends and listeners. Since MFM launched in January of 2016, Karen and Georgia have shared their lifelong interest in true crime and have covered stories of infamous serial killers like the Night Stalker, mysterious cold cases, captivating cults, incredible survivor stories and important events from history like the Tulsa race massacre of 1921. My Favorite Murder is part of the Exactly Right podcast network that provides a platform for bold, creative voices to bring to life provocative, entertaining and relatable stories for audiences everywhere. The Exactly Right roster of podcasts covers a variety of topics including historic true crime, comedic interviews and news, science, pop culture and more. Podcasts on the network include Buried Bones with Kate Winkler Dawson and Paul Holes, That's Messed Up: An SVU Podcast, This Podcast Will Kill You, Bananas and more.
The Joe Rogan Experience
The official podcast of comedian Joe Rogan.